Transcript Clinical Slide Set. Stable Ischemic Heart Disease

* For Best Viewing:
Open in Slide Show Mode
Click on
icon
or
From the View menu, select the
Slide Show option
* To help you as you prepare a talk, we have included the
relevant text from ITC in the notes pages of each slide
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Terms of Use
 The In the Clinic® slide sets are owned and copyrighted by the
American College of Physicians (ACP). All text, graphics,
trademarks, and other intellectual property incorporated into the
slide sets remain the sole and exclusive property of ACP. The slide
sets may be used only by the person who downloads or purchases
them and only for the purpose of presenting them during not-forprofit educational activities. Users may incorporate the entire slide
set or selected individual slides into their own teaching
presentations but may not alter the content of the slides in any way
or remove the ACP copyright notice. Users may make print copies
for use as hand-outs for the audience the user is personally
addressing but may not otherwise reproduce or distribute the slides
by any means or media, including but not limited to sending them as
e-mail attachments, posting them on Internet or Intranet sites,
publishing them in meeting proceedings, or making them available
for sale or distribution in any unauthorized form, without the
express written permission of the ACP. Unauthorized use of the In
the Clinic slide sets constitutes copyright infringement.
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
in the clinic
Stable Ischemic
Heart Disease
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Why is it important to differentiate
SIHD from unstable angina?
 Stable angina
 Typically brought on by exertion or emotion
 Unstable angina
 More random and unpredictable, occurring without trigger
 Rest angina: Occurring at rest and lasting >20 minutes
 New-onset severe angina: Severe onset ≤2 months of initial
presentation
 Increasing angina: Previously diagnosed, crescendo pattern
 Manage low-risk unstable angina the same as SIHD
 Manage intermediate- or high-risk unstable angina more
aggressively
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
What other diseases might be confused
with stable ischemic heart disease?
 Nonischemic CV: aortic dissection, pericarditis
 Pulmonary: embolus, pneumothorax, pneumonia, pleuritis
 Esophageal: esophagitis, spasm, reflux
 Biliary: colic, cholecystitis, choledocholithiasis, cholangitis
 Peptic ulcer
 Pancreatitis
 Chest wall: costochondrosis, fibrositis, rib fracture,
sternoclavicular arthritis, herpes zoster (before the rash)
 Psychiatric: anxiety/ affective/ somatoform/ thought disorders
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Why is it important to estimate the probability
of disease separately from the mortality risk?
 If <5% probability of CAD: look for other causes of pain
 Predictors of CAD
 Patient age, sex, and type of angina
 Smoking history, hyperlipidemia, diabetes
Clinical Classification of Chest Pain
 Typical angina (definite)
 Substernal chest discomfort: characteristic quality, duration
 Provoked by stress; relieved by rest or nitroglycerin
 Atypical angina (probable)
 Meets 2 of the above characteristics
 Noncardiac chest pain
 Meets ≤1 of typical angina characteristics
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
How should information from the physical
exam be used to evaluate people with SIHD?
 May reveal related conditions (HF, valvular heart disease)
 Signs suggesting CAD (only present during chest pain)
 S3 or S4 gallop, mitral regurgitant murmur, bibasilar rales,
paradoxically split S2, or chest wall heave
 Signs of CHD
 Jugular venous pulsation, S3 gallop, mitral regurgitation
murmur, displaced apical impulse, pulmonary crackles,
diminished breath sounds, dullness to percussion, abdominojugular reflux, hepatomegaly, lower extremity edema
 Signs of noncoronary atherosclerotic vascular disease
 Carotid bruit, diminished / absent pedal pulses, abdominal
aneurysms
 Xanthelasma and xanthomas: hyperlipidemias
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
What other preliminary tests should be
used to evaluate people with suspected
SIHD?
 Electrocardiogram
 All patients: resting ECG
 Chest X-ray
 If no obvious noncardiac cause of angina
 Echocardiography (rest)
 If patient has signs or symptoms suggesting HF or cardiac
valvular lesions
 If ECG findings show a pathologic Q-wave
 If ECG findings show complex ventricular arrhythmias
 Not recommended for most patients with SIHD
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Which diagnostic test should follow the
preliminary assessment?
 Standard exercise ECG
 If exercise ECG can’t be interpreted / performed:
 If due to left bundle branch block: Pharmacologic stress test
with imaging (radionuclide perfusion of myocardium / ECHO)
 If due to other abnormalities: Exercise stress test with
imaging (radionuclide perfusion of myocardium / ECHO)
 If patient can’t exercise: Pharmacologic stress test with
imaging (radionuclide perfusion of myocardium / ECHO)
 Coronary artery calcium for assessment: uncertain
 Low coronary artery calcium score identifies people w/o CAD
 High score is less reliable in ruling in CAD
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Duke Treadmill Score
 Predicts mortality risk based on ECG once the diagnosis is
established
 If ≥ +5: estimated cardiac mortality rate ≤ 1%/y, usually no
further risk assessment required
 If < +5 and ≥ -10: use stress imaging or coronary angiography
to stratify into low-risk and high-risk groups
 If < -10: annual mortality ≥ 3%, consider for revascularization
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
When should clinicians refer patients with
suspected ischemic heart disease to
specialists?
 Consult a cardiologist when…
 Diagnosis uncertain after noninvasive testing
 Noninvasive testing is contraindicated
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
When should coronary angiography be
used as the initial test to evaluate people
with suspected ischemic heart disease?
 Patients have survived sudden cardiac death or a lifethreatening ventricular arrhythmia
 Patients have a high likelihood of severe CAD
 Coronary artery spasm strongly suspected
 Some patients with HF
 Some employers require before allowing return to work
 Regardless of the results from noninvasive testing
 Pilots, firefighters, police force
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
CLINICAL BOTTOM LINE: Diagnosis…
 Predictors of CAD
 Age, sex, type of chest pain
 Smoking history, hyperlipidemia, diabetes mellitus
Physical exam
 Identify cardiac disease other than CAD
 Identify comorbid diseases exacerbating angina
 Diagnostic tests
 Resting ECG and chest x-ray
 Exercise ECG: CAD probability, mortality risk
 Coronary angiography: specific, limited subset of patients
Consult cardiologist if:
 Diagnosis uncertain after noninvasive testing
 Noninvasive testing contraindicated
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
What are the goals of treatment?
 Minimize likelihood of death & maximize health and function
 Reduce premature CV death
 Prevent complications that impair functional well-being
 Strategies for achieving treatment goals
 Patient education
 Lifestyle modification
 Medical therapy
 Revascularization (coronary artery bypass grafting or PCI)
 Use guideline-directed medical therapy — whether or not
revascularization occurs
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
What is the role of patient education?
 Reduce risk factors
 Improve medication adherence
 Improve patient satisfaction
 Should include:
 Review of individual prognosis and important risk factors
 Ways to reduce these risk factors
 Benefits + side effects of medications and how to administer
 Address limitations on physical activity
 When to seek medical help
 MI signs, symptoms; when to use aspirin, nitroglycerin
 What to do in an emergency
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Which risk factors should be modified?
 Smoking
 Recommend smoking cessation and develop cessation plan
 Physical activity
 If angina chronic + stable: moderate aerobic activity ≥5 d/wk
 If high risk of cardiac complications: medically supervised
program helps establish safe exercise regimen
 Dietary modification
 Diet low in saturated fat, cholesterol, trans-fatty acids, and
sodium and rich in fresh fruits, vegetables, whole grains
 Omega-3 fatty acids, plant stanols/sterols, fiber: reduce risk
 If alcohol is part of the diet, consumption should be moderate
 Lipid management
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Which medical therapies can prevent
myocardial infarction or death?
 Antiplatelet therapy
 Annual influenza vaccine
 ACE inhibitors
 Angiotensin-receptor antagonists
 Beta-blocker therapy
 Vitamins and mineral supplements aren’t recommended
for preventing CAD events
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Which medical therapies relieve symptoms?
 Short-acting nitrates
 β-blocker Therapy
 Calcium-channel blockers and long-acting nitrates
 Ranolazine
 Alternative therapies for refractory angina in SIHD
 Spinal cord stimulation
 Enhanced external counterpulsation
 Transmyocardial revascularization
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Which patients with SIHD are candidates for
revascularization with either CABG or a
PCI?
 To improve survival if mortality risk is high
 Left main or complex CAD
 >50% stenosis in left main coronary artery
 >70% in 3 major coronary arteries
 >70% in proximal left anterior descending artery + 1 other
major coronary artery
 Survivors of sudden cardiac death
(presumed ischemia-mediated ventricular tachycardia from
>70% stenosis in major coronary artery)
 To relieve symptoms if they persist despite therapy
 For stenosis likely to affect survival: same recommendations
 Other patients with >70% stenosis in ≥1 coronary arteries
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
Are there special considerations for women,
older adults, or patients with diabetes
mellitus, CKD, or other conditions?
 Women
 More atypical chest pain + angina-equivalent symptoms
 Tend to be treated less aggressively (bc different presentation
and testing compared to men?)
 Older adults
 Diagnosis and stress testing harder due to physiologic
changes of aging, coexisting conditions
 Receive less evidence-based care (bc pharmacotherapy
more difficult? bc of increased CABG morbidity, mortality?)
 Diabetes mellitus
 Greater risk of SIHD + magnified effects of other risk factors
 Chronic kidney disease
 Greater risk of SIHD + poor outcomes after AMI interventions
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
How should patients with treated ischemic
heart disease be followed?
 Each visit: obtain detailed information on angina
 Decreased level of physical activity since the last visit?
 Has angina increased in frequency or become more severe?
 Are risk factors modified and IHD knowledge improved?
 Any new comorbid illnesses?
 Has severity or treatment of comorbid illnesses worsened
angina?
 Assess adherence to therapy and AEs
 Encourage smoking cessation, exercise, balanced diet
 Use lab evaluation to monitor modifiable risk factors
 ECHO / radionuclide imaging / stress test: new symptoms
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
What do professional organizations
recommend with regard to prevention,
screening, diagnosis and treatment of
SIHD?
 Use 2012 clinical guideline for diagnosis and
management of SIHD

From the ACP, ACC Foundation, AHA, American
Association for Thoracic Surgery, Preventive
Cardiovascular Nurses Association, Society for
Cardiovascular Angiography and Interventions, and
Society of Thoracic Surgeons
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.
CLINICAL BOTTOM LINE: Treatment…
 Minimize likelihood of death & maximize health and function
 Use guideline-directed medical therapy
 Reduce risk factors with lifestyle modifications and medical Rx
 Patient education ensures
 Understanding of underlying disease process
 Understanding of warning signs and symptoms of MI
 Informed decisions about treatment options
Consider revascularization if mortality risk is high or
symptoms persist despite guideline-directed medical
therapy
© Copyright Annals of Internal Medicine, 2014
Ann Int Med. 160 (1): ITC1-1.